Clinical application of GnRH-antagonists

This publication has 17 references indexed in Scilit:

• GnRH antagonists
  Fertility and Sterility, 2000
• A double-blind, randomized, dose-finding study to assess the efficacy of the gonadotrophin-releasing hormone antagonist ganirelix (Org 37462) to prevent premature luteinizing hormone surges in women undergoing ovarian stimulation with recombinant follicle stimulating hormone (Puregon). The ganirelix dose-finding study group
  Human Reproduction, 1998
• Treatment of uterine fibroids with a slow-release formulation of the gonadotrophin releasing hormone antagonist Cetrorelix
  Human Reproduction, 1998
• Comparison of different doses of gonadotropin-releasing hormone antagonist Cetrorelix during controlled ovarian hyperstimulation
  Fertility and Sterility, 1997
• EndocrinologyHormonal profile during the follicular phase in cycles stimulated with a combination of human menopausal gonadotrophin and gonadotrophin-releasing hormone antagonist (Cetrorelix)
  Human Reproduction, 1996
• Hormone profiles under ovarian stimulation with human menopausal gonadotropin (hMG) and concomitant administration of the gonadotropin releasing hormone (GnRH)-antagonist Cetrorelix at different dosages
  Journal of Assisted Reproduction and Genetics, 1996
• Preserved pituitary response under ovarian stimulation with HMG and GnRH antagonists (Cetrorelix) in women with tubal infertility
  European Journal of Obstetrics & Gynecology and Reproductive Biology, 1995
• Endocrinology of the ovary
  Human Reproduction, 1994
• The gonadotropin-releasing hormone antagonist (Nal-Glu) acutely blocks the luteinizing hormone surge but allows for resumption of folliculogenesis in normal women
  American Journal of Obstetrics and Gynecology, 1991
• Recovery of Pituitary-Gonadal Function in Male and Female Rats after Prolonged Administration of a Potent Antagonist of Luteinizing Hormone-Releasing Hormone (SB-75)
  Neuroendocrinology, 1991